Literature DB >> 17258505

Oral mucositis and quality of life of Hong Kong Chinese patients with cancer therapy.

Karis Kin-Fong Cheng1.   

Abstract

Oral mucositis associated with cancer therapy often has devastating impact on patients' quality of life (QoL), affecting multiple spheres of daily and psychosocial functioning. This descriptive cross-sectional study aimed at describing the severity and distress of oral mucositis, as well as QoL of Hong Kong Chinese patients treated with cancer therapy, and identifying the extent to which oral mucositis correlated with QoL. A convenience sample of 38 in-patients and 50 out-patients with solid tumors and during the peak phase of oral mucositis was recruited. The severity and distress of oral mucositis were assessed by a 4-point rating scale ranging from 1 (mild) to 4 (very severe) and 5-point rating scale ranging from 0 (not at all) to 4 (very much), respectively. The QoL was assessed by the Chinese version Functional Assessment of Cancer Therapy-General questionnaires (Ch-FACT-G). The mean+/-SD severity and distress scores of oral mucositis were 2.1+/-0.9 and 1.6+/-1.2, respectively. The total mean+/-SD scores of physical, social/family, emotional, and functional subscales of the Ch-FACT-G were 15.1+/-5.9, 16.3+/-4.1, 15.7+/-4.5, and 11.9+/-6.8 separately. The physical subscale of the Ch-FACT-G significantly correlated with the severity (r=0.305, P<0.01) and the distress (r=0.355, P<0.01) of oral mucositis. A significantly mild positive correlation was also found between the emotional subscale of the Ch-FACT-G and the severity of oral mucositis (r=0.314, P<0.01). Subjects receiving radiotherapy reported a lower range of total social/family, emotional, and functional subscale scores than that of those receiving chemotherapy or chemo-radiotherapy, but these differences were not statistically significant (P>0.05). In conclusion, QoL, especially the functional sphere, was compromised for patients with oral mucositis. The data also support the correlations between oral mucositis and the physical sphere of QoL, as well as oral mucositis and the emotional sphere of QoL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17258505     DOI: 10.1016/j.ejon.2006.03.004

Source DB:  PubMed          Journal:  Eur J Oncol Nurs        ISSN: 1462-3889            Impact factor:   2.398


  11 in total

1.  Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy.

Authors:  Jin Won Kim; Yongjun Cha; Su-Jung Kim; Sae-Won Han; Do-Youn Oh; Se-Hoon Lee; Dong-Wan Kim; Seock-Ah Im; Tae-You Kim; Dae Seog Heo; Yung-Jue Bang
Journal:  Support Care Cancer       Date:  2011-03-11       Impact factor: 3.603

2.  A patient-reported outcome instrument to assess the impact of oropharyngeal mucositis on health-related quality of life: a longitudinal psychometric evaluation.

Authors:  Karis K F Cheng; S F Leung; Raymond H S Liang; Josepha W M Tai; Rebecca M W Yeung; David R Thompson
Journal:  Support Care Cancer       Date:  2008-08-02       Impact factor: 3.603

3.  Role of the cyclooxygenase pathway in chemotherapy-induced oral mucositis: a pilot study.

Authors:  Rajesh V Lalla; Carol C Pilbeam; Stephen J Walsh; Stephen T Sonis; Dorothy M K Keefe; Douglas E Peterson
Journal:  Support Care Cancer       Date:  2009-04-29       Impact factor: 3.603

4.  Patient and oncologist perceptions regarding symptoms and impact on quality-of-life of oral mucositis in cancer treatment: results from the Awareness Drives Oral Mucositis PercepTion (ADOPT) study.

Authors:  Jeevendra Kanagalingam; Mohamed Ibrahim A Wahid; Jin-Ching Lin; Nonette A Cupino; Edward Liu; Jin-Hyoung Kang; Shouki Bazarbashi; Nicole Bender Moreira; Harsha Arumugam; Stefan Mueller; Hanlim Moon
Journal:  Support Care Cancer       Date:  2018-01-31       Impact factor: 3.603

5.  Reduction of Opioid Use by Acupuncture in Patients Undergoing Hematopoietic Stem Cell Transplantation: Secondary Analysis of a Randomized, Sham-Controlled Trial.

Authors:  Gary Deng; Sergio Giralt; David J Chung; Heather Landau; Jonathan Siman; Qing S Li; Kaitlyn Lapen; Jun J Mao
Journal:  Pain Med       Date:  2020-03-01       Impact factor: 3.750

6.  Burden of oral mucositis in stem cell transplant patients-the patients' perspective.

Authors:  Tim Staudenmaier; Irena Cenzer; Alexander Crispin; Helmut Ostermann; Karin Berger
Journal:  Support Care Cancer       Date:  2017-12-02       Impact factor: 3.603

7.  Incidence and Risk Factors of Oral Mucositis in Patients with Breast Cancer Who Receiving Chemotherapy in Al-Bashir Hospital.

Authors:  Ahmed A Al Ibraheemi; Shaimaa Shamoun
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2016-10-01

8.  Measuring the Quality of Life among Head-and/or-Neck Cancer Patients with Oral Mucositis Using the Functional Assessment of Cancer Therapy-General in Jordan.

Authors:  Marwa Al Barmawi; Lourance A Al Hadid; Hani Nawaf Alqudah; Wasfi A Al Hadid; Shaimaa A Shamoun
Journal:  Asia Pac J Oncol Nurs       Date:  2018 Jul-Sep

Review 9.  Dermatologic conditions in women receiving systemic cancer therapy.

Authors:  Michelle N Ferreira; Julie Y Ramseier; Jonathan S Leventhal
Journal:  Int J Womens Dermatol       Date:  2019-11-07

Review 10.  Impact of oral mucositis on quality of life in patients undergoing oncological treatment: a systematic review.

Authors:  Ali Hatem Manfi Al-Rudayni; Divya Gopinath; Mari Kannan Maharajan; Rohit Kunnath Menon
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.